From: The Honorable David W. Jolly
Sent By:
Bill: H.R. 4640
Date: 5/25/2016

Supported by AMVETS, American Legion, DAV, Fleet Reserve Association, and Gold Star Wives of America

Current cosponsors: (50) Jolly, Titus, Abraham, Bishop, Brat, Byrne, Coffman, Cole,
Conyers, DeLauro, DeSaulnier, Dingell, Dold, Gabbard, Gallego, Grijalva, Hill, Honda,
Jones, Joyce, Keating,
Kilmer, King (NY), Kirkpatrick, Lamborn, Lawrence, LoBiondo, Loudermilk, Lowenthal, Lynch, Massie, McGovern, Moulton, Olson, O’Rourke, Peters, Quigley, Swalwell, Rangel, Ratcliffe, Ross, Rush, Smith (NJ), Stefanik, Stewart, Van Hollen, Welch, Wilson, Young (IA), Yarmuth

Dear Colleague,

We invite you to join us in cosponsoring H.R. 4640, the Veteran Suicide Prevention Act, which would require the Department of Veterans Affairs (VA) to conduct a review of veteran suicide deaths over the past five years, paying specific attention to the medications prescribed to veterans at the time of their death.

It is critical that we understand whether there is any impact of certain drugs with black box warnings prescribed for issues like PTSD, depression or traumatic brain injuries, on the decision of a veteran to take his or her own life. With veterans dying
by suicide at a heartbreaking rate, we need to take a hard look at all possible factors in order to help prevent these tragedies.

Among other specifications, the Veteran Suicide Prevention Act would require the VA to record the total number of veterans who have died by suicide during the past five years, compile a comprehensive list of the medications prescribed to and found
in the systems of such veterans at the time of their deaths, and report which Veterans Health Administration facilities have disproportionately high rates of psychiatric drug prescription and suicide among veterans treated at those facilities.  The VA would
then be required to submit to Congress a publicly available report on the results of their review, along with their plan of action for improving the safety and well-being of veterans.

For more information or to be a cosponsor, please contact Ian Manzano in Congressman Jolly’s office at or David Rosenbaum in Congresswoman Titus’s office at


David W. Jolly                                    Dina Titus
Member of Congress                           Member of Congress